Publication | Closed Access

Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro

Hematological MalignancyMalignant Blood DisorderImmunologyHematologyMyeloma CellsAutoimmunityDendritic Cell BiologyImmunotherapyMedicineCell BiologyMyelopoiesisDendritic Cells